APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Motility Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastric Motility Disorder Drug Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchGastric Motility Disorder Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Motility Disorder Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Gastric Motility Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Motility Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Motility Disorder Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gastric Motility Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastric Motility Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastric Motility Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastric Motility Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastric Motility Disorder Drug include Theravance, Inc., Targacept, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc. and ChironWells GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastric Motility Disorder Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastric Motility Disorder Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastric Motility Disorder Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastric Motility Disorder Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastric Motility Disorder Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastric Motility Disorder Drug Market by Company

Theravance, Inc.

Targacept, Inc.

Helsinn Healthcare S.A.

Concert Pharmaceuticals, Inc.

ChironWells GmbH

Gastric Motility Disorder Drug Segment by Type

Ipamorelin

Velusetrag

TD-8954

Others

Gastric Motility Disorder Drug Segment by Application

Hospital

Clinic

Home Use

Gastric Motility Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Motility Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Motility Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Motility Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastric Motility Disorder Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastric Motility Disorder Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ipamorelin Table 2. Major Company of Velusetrag Table 3. Major Company of TD-8954 Table 4. Major Company of Others Table 5. Global Gastric Motility Disorder Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Gastric Motility Disorder Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Gastric Motility Disorder Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Gastric Motility Disorder Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Gastric Motility Disorder Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Gastric Motility Disorder Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Gastric Motility Disorder Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Gastric Motility Disorder Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Gastric Motility Disorder Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Gastric Motility Disorder Drug Industry Trends Table 27. Gastric Motility Disorder Drug Industry Drivers Table 28. Gastric Motility Disorder Drug Industry Opportunities and Challenges Table 29. Gastric Motility Disorder Drug Industry Restraints Table 30. Global Gastric Motility Disorder Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Gastric Motility Disorder Drug Revenue Market Share by Company (2021-2026) Table 32. Global Gastric Motility Disorder Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Gastric Motility Disorder Drug Sales Share by Company (2021-2026) Table 34. Global Gastric Motility Disorder Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Gastric Motility Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Gastric Motility Disorder Drug Major Company Production Sites and Headquarters Table 37. Global Gastric Motility Disorder Drug Company, Product Type & Application Table 38. Global Gastric Motility Disorder Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Gastric Motility Disorder Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Gastric Motility Disorder Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Gastric Motility Disorder Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Gastric Motility Disorder Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Gastric Motility Disorder Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Gastric Motility Disorder Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Gastric Motility Disorder Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Gastric Motility Disorder Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Gastric Motility Disorder Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Gastric Motility Disorder Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Gastric Motility Disorder Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Gastric Motility Disorder Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gastric Motility Disorder Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Gastric Motility Disorder Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Gastric Motility Disorder Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Gastric Motility Disorder Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Gastric Motility Disorder Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Theravance, Inc. Company Information Table 74. Theravance, Inc. Business Overview Table 75. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Theravance, Inc. Gastric Motility Disorder Drug Product Portfolio Table 77. Theravance, Inc. Recent Development Table 78. Targacept, Inc. Company Information Table 79. Targacept, Inc. Business Overview Table 80. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Targacept, Inc. Gastric Motility Disorder Drug Product Portfolio Table 82. Targacept, Inc. Recent Development Table 83. Helsinn Healthcare S.A. Company Information Table 84. Helsinn Healthcare S.A. Business Overview Table 85. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Portfolio Table 87. Helsinn Healthcare S.A. Recent Development Table 88. Concert Pharmaceuticals, Inc. Company Information Table 89. Concert Pharmaceuticals, Inc. Business Overview Table 90. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Portfolio Table 92. Concert Pharmaceuticals, Inc. Recent Development Table 93. ChironWells GmbH Company Information Table 94. ChironWells GmbH Business Overview Table 95. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. ChironWells GmbH Gastric Motility Disorder Drug Product Portfolio Table 97. ChironWells GmbH Recent Development Table 98. North America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 99. North America Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 100. North America Gastric Motility Disorder Drug Sales Market Share by Country (2021-2026) Table 101. North America Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 102. North America Gastric Motility Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 103. North America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Gastric Motility Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Gastric Motility Disorder Drug Market Share by Country (2021-2026) Table 106. North America Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Gastric Motility Disorder Drug Market Share Forecast by Country (2027-2032) Table 108. Europe Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. Europe Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 110. Europe Gastric Motility Disorder Drug Sales Market Share by Country (2021-2026) Table 111. Europe Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 112. Europe Gastric Motility Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Gastric Motility Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Gastric Motility Disorder Drug Market Share by Country (2021-2026) Table 116. Europe Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Gastric Motility Disorder Drug Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 120. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 122. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Gastric Motility Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Gastric Motility Disorder Drug Market Share by Country (2021-2026) Table 126. Asia-Pacific Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Gastric Motility Disorder Drug Market Share Forecast by Country (2027-2032) Table 128. Latin America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Latin America Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 130. Latin America Gastric Motility Disorder Drug Sales Market Share by Country (2021-2026) Table 131. Latin America Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 132. Latin America Gastric Motility Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Gastric Motility Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Gastric Motility Disorder Drug Market Share by Country (2021-2026) Table 136. Latin America Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Gastric Motility Disorder Drug Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2021-2026) & (K Units) Table 140. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032) & (K Units) Table 142. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Gastric Motility Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Gastric Motility Disorder Drug Market Share by Country (2021-2026) Table 146. Middle East and Africa Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Gastric Motility Disorder Drug Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Gastric Motility Disorder Drug Distributors List Table 151. Gastric Motility Disorder Drug Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Gastric Motility Disorder Drug Image Figure 2. Global Gastric Motility Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastric Motility Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastric Motility Disorder Drug Sales (2021-2032) & (K Units) Figure 5. Ipamorelin Image Figure 6. Global Ipamorelin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Velusetrag Image Figure 8. Global Velusetrag Sales YoY Growth (2021-2032) & (K Units) Figure 9. TD-8954 Image Figure 10. Global TD-8954 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Gastric Motility Disorder Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Gastric Motility Disorder Drug Market Share by Type 2025 VS 2032 Figure 15. North America Gastric Motility Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Gastric Motility Disorder Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Gastric Motility Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Gastric Motility Disorder Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Gastric Motility Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Gastric Motility Disorder Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Gastric Motility Disorder Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Home Use Image Figure 32. Global Home Use Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Gastric Motility Disorder Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Gastric Motility Disorder Drug Market Share by Application 2025 VS 2032 Figure 35. North America Gastric Motility Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Gastric Motility Disorder Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Gastric Motility Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Gastric Motility Disorder Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Gastric Motility Disorder Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Gastric Motility Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Gastric Motility Disorder Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Gastric Motility Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Gastric Motility Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Gastric Motility Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Gastric Motility Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gastric Motility Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Gastric Motility Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastric Motility Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Gastric Motility Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gastric Motility Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Gastric Motility Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastric Motility Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Gastric Motility Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gastric Motility Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Gastric Motility Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastric Motility Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Gastric Motility Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gastric Motility Disorder Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Gastric Motility Disorder Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastric Motility Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Gastric Motility Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Gastric Motility Disorder Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Gastric Motility Disorder Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ipamorelin
  • Velusetrag
  • TD-8954
  • Others
Applications
  • Hospital
  • Clinic
  • Home Use
Companies covered
  • Theravance, Inc.
  • Targacept, Inc.
  • Helsinn Healthcare S.A.
  • Concert Pharmaceuticals, Inc.
  • ChironWells GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastric Motility Disorder Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastric Motility Disorder Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastric Motility Disorder Drug Market by Type
  6. 1.3.1 Ipamorelin
  7. 1.3.2 Velusetrag
  8. 1.3.3 TD-8954
  9. 1.3.4 Others
  10. 1.4 Global Gastric Motility Disorder Drug Market Size by Type
  11. 1.4.1 Global Gastric Motility Disorder Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Gastric Motility Disorder Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Gastric Motility Disorder Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Gastric Motility Disorder Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Gastric Motility Disorder Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Gastric Motility Disorder Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Gastric Motility Disorder Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Gastric Motility Disorder Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastric Motility Disorder Drug Industry Trends
  2. 2.2 Gastric Motility Disorder Drug Industry Drivers
  3. 2.3 Gastric Motility Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Gastric Motility Disorder Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastric Motility Disorder Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastric Motility Disorder Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Gastric Motility Disorder Drug Price (2021-2026)
  4. 3.4 Global Gastric Motility Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastric Motility Disorder Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Gastric Motility Disorder Drug Company, Product Type & Application
  7. 3.7 Global Gastric Motility Disorder Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastric Motility Disorder Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastric Motility Disorder Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastric Motility Disorder Drug Tier 1, Tier 2, and Tier 3
4 Gastric Motility Disorder Drug Regional Status and Outlook
  1. 4.1 Global Gastric Motility Disorder Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastric Motility Disorder Drug Historic Market Size by Region
  3. 4.2.1 Global Gastric Motility Disorder Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastric Motility Disorder Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastric Motility Disorder Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastric Motility Disorder Drug Forecasted Market Size by Region
  7. 4.3.1 Global Gastric Motility Disorder Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastric Motility Disorder Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastric Motility Disorder Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastric Motility Disorder Drug by Application
  1. 5.1 Gastric Motility Disorder Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Home Use
  5. 5.2 Global Gastric Motility Disorder Drug Market Size by Application
  6. 5.2.1 Global Gastric Motility Disorder Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gastric Motility Disorder Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gastric Motility Disorder Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gastric Motility Disorder Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gastric Motility Disorder Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gastric Motility Disorder Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gastric Motility Disorder Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gastric Motility Disorder Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Theravance, Inc.
  2. 6.1.1 Theravance, Inc. Company Information
  3. 6.1.2 Theravance, Inc. Business Overview
  4. 6.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Theravance, Inc. Gastric Motility Disorder Drug Product Portfolio
  6. 6.1.5 Theravance, Inc. Recent Developments
  7. 6.2 Targacept, Inc.
  8. 6.2.1 Targacept, Inc. Company Information
  9. 6.2.2 Targacept, Inc. Business Overview
  10. 6.2.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Targacept, Inc. Gastric Motility Disorder Drug Product Portfolio
  12. 6.2.5 Targacept, Inc. Recent Developments
  13. 6.3 Helsinn Healthcare S.A.
  14. 6.3.1 Helsinn Healthcare S.A. Company Information
  15. 6.3.2 Helsinn Healthcare S.A. Business Overview
  16. 6.3.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Portfolio
  18. 6.3.5 Helsinn Healthcare S.A. Recent Developments
  19. 6.4 Concert Pharmaceuticals, Inc.
  20. 6.4.1 Concert Pharmaceuticals, Inc. Company Information
  21. 6.4.2 Concert Pharmaceuticals, Inc. Business Overview
  22. 6.4.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Portfolio
  24. 6.4.5 Concert Pharmaceuticals, Inc. Recent Developments
  25. 6.5 ChironWells GmbH
  26. 6.5.1 ChironWells GmbH Company Information
  27. 6.5.2 ChironWells GmbH Business Overview
  28. 6.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ChironWells GmbH Gastric Motility Disorder Drug Product Portfolio
  30. 6.5.5 ChironWells GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Gastric Motility Disorder Drug Sales by Country
  2. 7.1.1 North America Gastric Motility Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastric Motility Disorder Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastric Motility Disorder Drug Market Size by Country
  6. 7.2.1 North America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastric Motility Disorder Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastric Motility Disorder Drug Sales by Country
  2. 8.1.1 Europe Gastric Motility Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastric Motility Disorder Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastric Motility Disorder Drug Market Size by Country
  6. 8.2.1 Europe Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastric Motility Disorder Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastric Motility Disorder Drug Sales by Country
  2. 9.1.1 Asia-Pacific Gastric Motility Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastric Motility Disorder Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastric Motility Disorder Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastric Motility Disorder Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastric Motility Disorder Drug Sales by Country
  2. 10.1.1 South America Gastric Motility Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastric Motility Disorder Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastric Motility Disorder Drug Market Size by Country
  6. 10.2.1 South America Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastric Motility Disorder Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Country
  2. 11.1.1 Middle East and Africa Gastric Motility Disorder Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastric Motility Disorder Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastric Motility Disorder Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Gastric Motility Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastric Motility Disorder Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastric Motility Disorder Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastric Motility Disorder Drug Value Chain Analysis
  2. 12.1.1 Gastric Motility Disorder Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastric Motility Disorder Drug Production Mode & Process
  7. 12.2 Gastric Motility Disorder Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastric Motility Disorder Drug Distributors
  10. 12.2.3 Gastric Motility Disorder Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst